Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BUTORPHANOL vs CABERGOLINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BUTORPHANOL vs CABERGOLINE: Safety Overview

Metric BUTORPHANOL CABERGOLINE
Total FAERS Reports 462 2,099
Deaths Reported 10 72
Death Rate 2.2% 3.4%
Hospitalizations 24 573
Average Patient Age 53.9 yrs 42.9 yrs
% Female Patients 79.2% 59.6%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 21, 2008
Manufacturer Hikma Pharmaceuticals USA Inc. SOLA Pharmaceuticals, LLC
Route NASAL ORAL
Marketing Status Discontinued Discontinued